Evolution of myeloid-mediated immunotherapy resistance in prostate cancer
Most Cited Paper
in Immunotherapy and Immune Responses
18 Months Post-Publication
Class of 2026
“Evolution of myeloid-mediated immunotherapy resistance in prostate cancer”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/immunotherapy-and-immune-responses/2026/
Topics
Metastatic castration-resistant prostate cancer · Metastatic castration-resistant prostate cancer · immune checkpoint inhibitors · SPP1hi tumor-associated macrophages · SPP1hi tumor-associated macrophages · CSF1R blockade · single-cell analysis · CD8+ T cell suppression · adenosine signaling · adenosine A2A receptors · A2AR inhibition · ciforadenant · PD-1 inhibition · PD-L1 inhibition · atezolizumab · immunotherapy resistance · myeloid-mediated immunosuppression · syngeneic mouse models · ICI resistance mechanisms
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Immunotherapy and Immune Responses Papers, Class of 2026. https://pri.pepkio.com/top-papers/immunotherapy-and-immune-responses/2026. Accessed 2026-07-20. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459